On Friday, Mirum Pharmaceuticals Inc (NASDAQ: MIRM) was 2.69% up from the session before settling in for the closing price of $41.98. A 52-week range for MIRM has been $23.14 – $45.23.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 88.90% over the last five years. When this article was written, the company’s average yearly earnings per share was at 55.09%. With a float of $37.84 million, this company’s outstanding shares have now reached $46.72 million.
The firm has a total of 264 workers. Let’s measure their productivity. In terms of profitability, gross margin is 73.13%, operating margin of -40.07%, and the pretax margin is -39.69%.
Mirum Pharmaceuticals Inc (MIRM) Breakdown of a Key Holders of the stock
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Mirum Pharmaceuticals Inc stocks. The insider ownership of Mirum Pharmaceuticals Inc is 20.68%, while institutional ownership is 96.03%. The most recent insider transaction that took place on Jul 02 ’24, was worth 12,750. In this transaction SVP, GLOBAL CONTROLLER of this company sold 375 shares at a rate of $34.00, taking the stock ownership to the 2,426 shares. Before that another transaction happened on Jun 24 ’24, when Company’s CHIEF SCIENTIFIC OFFICER sold 30,559 for $34.00, making the entire transaction worth $1,039,006. This insider now owns 27,406 shares in total.
Mirum Pharmaceuticals Inc (MIRM) Recent Fiscal highlights
Going through the last 3-months fiscal report unveiled on the 6/30/2024, it has been observed that the corporation posted -0.57 earnings per share (EPS) during the time that was better than consensus figure (set at -0.63) by 0.06. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.34 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 55.09% per share during the next fiscal year.
Mirum Pharmaceuticals Inc (NASDAQ: MIRM) Trading Performance Indicators
You can see what Mirum Pharmaceuticals Inc (MIRM) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 3.09. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 7.78.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.34, a number that is poised to hit -0.43 in the next quarter and is forecasted to reach -0.81 in one year’s time.
Technical Analysis of Mirum Pharmaceuticals Inc (MIRM)
Analysing the last 5-days average volume posted by the [Mirum Pharmaceuticals Inc, MIRM], we can find that recorded value of 0.43 million was lower than the volume posted last year of 0.62 million. As of the previous 9 days, the stock’s Stochastic %D was 52.77%. Additionally, its Average True Range was 1.93.
During the past 100 days, Mirum Pharmaceuticals Inc’s (MIRM) raw stochastic average was set at 90.40%, which indicates a significant increase from 57.17% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 51.06% in the past 14 days, which was lower than the 64.48% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $39.00, while its 200-day Moving Average is $30.46. Now, the first resistance to watch is $43.65. This is followed by the second major resistance level at $44.20. The third major resistance level sits at $45.02. If the price goes on to break the first support level at $42.28, it is likely to go to the next support level at $41.46. Now, if the price goes above the second support level, the third support stands at $40.91.
Mirum Pharmaceuticals Inc (NASDAQ: MIRM) Key Stats
There are 47,133K outstanding shares of the company, which has a market capitalization of 2.06 billion. As of now, sales total 186,370 K while income totals -163,420 K. Its latest quarter income was 77,880 K while its last quarter net income were -24,640 K.
